REGINA M DORMAN

Allopathic & Osteopathic Physicians|Family Medicine TALLMADGE, OH NPI 1699765404

General Payments — all program years on this page

$2,369.09

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 162
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $303.21 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $303.2119

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $518.6139
2019 $323.4424
2020 $98.197
2021 $256.1416
2022 $350.2519
2023 $519.2538
2024 $303.2119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096871587 Novo Nordisk Inc $13.26 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097063629 Novo Nordisk Inc $14.84 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097540641 Novo Nordisk Inc $13.42 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101471251 E.R. Squibb & Sons, L.L.C. $16.08 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103654342 ABBVIE INC. $21.05 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103654344 ABBVIE INC. $22.91 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104214935 AstraZeneca Pharmaceuticals LP $14.30 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104381733 AstraZeneca Pharmaceuticals LP $14.11 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104661791 AstraZeneca Pharmaceuticals LP $16.80 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116237303 GlaxoSmithKline, LLC. $16.47 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116332741 GlaxoSmithKline, LLC. $13.48 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118116279 Boehringer Ingelheim Pharmaceuticals, Inc. $16.07 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118116281 Boehringer Ingelheim Pharmaceuticals, Inc. $16.45 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118116283 Boehringer Ingelheim Pharmaceuticals, Inc. $17.81 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125204290 Abbott Laboratories $13.32 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131041242 PFIZER INC. $14.70 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135352914 Lilly USA, LLC $13.75 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148846371 Sumitomo Pharma America, Inc. $13.35 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151056615 Phathom Pharmaceuticals, Inc. $21.04 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.